Second Line Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Second Line Capital's MRK Position: Q1 2026 in Review
Second Line Capital increased its Merck (MRK) stake by 4% in Q1 2026, buying an estimated $25.9K and bringing the position to 5,874 shares worth $641K. The position accounts for 0.12% of the portfolio, ranked #76.
Second Line Capital first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Second Line Capital held 5,874 shares of Merck worth $641K as of Q1 2026.
- Second Line Capital bought 224 Merck shares in Q1 2026, an estimated $25.9K.
- Merck made up 0.12% of Second Line Capital's portfolio in Q1 2026, its #76 holding.
- Second Line Capital first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Second Line Capital's 13F filing for Q1 2026, filed 15 May 2026.